Results

Total Results: 1,474 records

Showing results for "indications".
Users also searched for: quality indicators

1. Evidence Report on the (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
   August 05, 2010 - Pharmacokinetics, Indications, and Dosing of drugs to be included. … (trade names provided only for drugs under patent) Drug (any trade name): acetaminophen Labeled indications … patients (Peds): 10−15 mg/kg/dose up to 5 doses/day Drug (any trade name): aspirin Labeled indications … weighing >60 kg: extended release,1000 mg 1x/day Drug (any trade name): fenoprofen Labeled indications … renal impairment: no dose adjustment necessary Drug (any trade name): flurbiprofen Labeled indications

2. Radiotherapy-Proton-Beam Research (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
   May 01, 2012 - CMS has yet to issue a national coverage rule for proton beam therapy or its specific indications. … A requirement (for some indications) that the patient be treated as part of a clinical trial. 4. … Providers must contact the contractor to discuss indications and payment. … Despite the rarity of commonly accepted indications such as tumors of the eye, skull base, and spinal … the LCDs listing specific indications. † Constitute separate categories in our analysis due to their

3. Layout 1 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
   May 01, 2010 - Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs … indications that are similar to hemophilia. … Studies on other indications were included in our survey of existing research. … Studies on other indications were included in our survey of existing research. … The rate of increase may be plateauing for many indications (Figure B).

4. Refining Key Questions: Interactive Case Study Quiz
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
   May 01, 2010 - Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. … Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. … Increasingly used off-label beyond hemophilia-related indications to prevent excessive bleeding for a … , and studies on the potential harms for the five indications were included. … There are no indications where potential risks are likely to greatly exceed the benefits.  

5. Refining Key Questions: Interactive Case Study Quiz
   effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
   May 01, 2010 - Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. … Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. … Increasingly used off-label beyond hemophilia-related indications to prevent excessive bleeding for a … , and studies on the potential harms for the five indications were included. … There are no indications where potential risks are likely to greatly exceed the benefits.  

6. Topic 0613 Tympanostomy Tubes NSD FINAL (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0765-150129.pdf
   November 03, 2014 - professional association Nomination The nominator asserts that there is clinical uncertainty regarding indications … effectiveness of obtaining a hearing test prior to inserting tympanostomy tubes to improve certainty of indications … tympanostomy tubes Intervention(s): Hearing testing Comparator(s): No test Outcome(s): Improvement in indications … What are the indications for inserting tympanostomy tubes (how many otitis media w/ effusion or acute … submit-a-suggestion-for-research/how-are-research- topics-chosen/.) § Tympanostomy tubes are used to treat different indications

7. Topic 0614 Tonsillectomy NSD FINAL CC (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0768-141211.pdf
   October 23, 2014 - s): Organization Nomination The nominator asserts that there is clinical uncertainty regarding indications … nomination notes recurrent throat infections and sleep disordered breathing (SDB) as the two most common indications … What are the appropriate indications for tonsillectomy? … The two most common indications for tonsillectomy in children are recurrent throat infections and sleep

8. Chicago-Area DEcIDE Center (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
   May 01, 2009 - Drug use for indications not approved by the Food and Drug Administration exceeds 20% of outpatient … Using the data and information on labeled indications available from the FDA, prescription uses were … While similar to the algorithm of Radley,9 we sought to explicitly consider those indications where … possible between NDTI ICD-9 codes and the DRUGDEX indications. … We assessed off-label use involving drugs used for indications not approved by the FDA.

9. uterine-fibroids-protocol-160301 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
   March 01, 2016 - :   Ovulation  induction     Non-­FDA  labeled  indications:   Uterine  leiomyoma   Merck  Serono   … Rockland,  MA     USA   Goserelin  Acetate     Zoladex®   FDA-­labeled  indications:  Breast  cancer … :   Prostate  cancer,  advanced     Non-­FDA  labeled  indications:   Central  precocious  puberty;; …  conception     Non  FDA-­labeled  indications:     Menorrhagia,  uterine  leiomyoma  (preoperative … :     Breast  cancer,  Invasive,  in  postmenopausal   women;;       Non-­FDA  labeled  indications:

10. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
    May 19, 2010 - insufficient high-quality evidence overall to reach conclusions about the efficacy of any off-label indications … treatment in October 2006) • Autism (included in the original systematic review1) and all on-label indications … they have been prescribed for other conditions; • New or increased adverse effects of off-label indications … Special attention will be given to identify the effective dose and time limit for off-label indications … The evidence of risks – adverse events associated with off-label indications – will be summarized, first

11. Stem-Cell-Children Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
    February 01, 2012 - A final list of indications for narrative reviews compiled by the EPC was posted for public comment … Systematic Reviews Table B shows the indications that were systematically reviewed. … Pediatric HSCT indications to be addressed with narrative review (continued) Type Disease Indication … Pediatric HSCT indications to be addressed with narrative review (continued) Type Disease Indication … Pediatric HSCT indications to be addressed with systematic review (continued) Type Disease Indication

12. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0030_06-19-2008.pdf
    January 01, 2008 - what mechanical thrombectomy devices are used in patients with acute coronary syndromes (ACSs), their indications … What are the indications for their use? 3.

13. Ced -Appendix-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
    May 29, 2025 - , without FDA-approval for marketing for these indications. … Deeply concerned about CMS’ employment of CED for FDA-approved drugs – whether for on-label indications … or other medically accepted indications. … , without FDA-approval for marketing for these indications. … or other medically accepted indications Patient access barriers under CED (equity) No clear pathway

14. White Paper: Enhancing Systematic Review Methods by Incorporating Unpublished Drug Trials (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/unpublished-drug-trials-white-paper.pdf
    December 01, 2024 - FDA-Approved Indications Versus Off-Label Uses: FDA reviews only cover drug- indication combinations … First Approved Versus Subsequently Approved Indications: Access to FDA reviews can vary. … Reviews are more reliably posted for first-approved indications (e.g., ziprasidone for schizophrenia … ) compared to subsequent indications (e.g., ziprasidone for acute bipolar mania).9 To check for the … indications.

15. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
    September 01, 2011 - Now, many have received FDA approval for indications to treatment these disorders. … And, as our report indicates, in this update there are more "new" off-label indications than there … are previous off-label indications that now have FDA approval. … In view of these approvals, these agents and indications might be left out of the current report on … I realize this will not be applicable to most of the off-label indications, but this would apply to

16. Recombinant-Factor-Viia Clinician (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
    October 01, 2010 - regarding the serious thrombotic events associated with the use of rFVIIa (NovoSeven® RT) outside labeled indications … is based on Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications … only given in the form of 1-2 infusions, rather than multiple infusions seen in some of the other indications

17. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0004_03-11-2008.pdf
    January 01, 2008 - topic will move forward for refinement as a systematic review with a focus on COPD and ACPE as primary indications … Topic refinement may consider an expansion of the scope to include other indications for which there

18. Introduction to N-of-1 Trials: Indications and Barriers (Chapter 1) | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/n-1-trials/research-2014-4

19. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
    June 01, 2010 - Review Title: Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications … Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care. … The Draft Report erroneously concludes that the use of rFVIIa outside of approved indications is now … The Draft Report erroneously concludes that the use of rFVIIa outside of approved indications is now … A similar analysis can be done for other indications.

20. Progestogens-Preterm-Birth Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
    September 01, 2012 - We constructed models to address two aspects of clinical utility—grouping the RCTs: (1) by the indications … Indications for treatment varied, including a history of preterm birth in 10 investigations, preterm … The heterogeneity of the studies that included women with varied indications for progestogen treatment … Categorization of indications in the largest database study found 79.5 percent had a prior preterm … Across indications, data are sparse to evaluate influence on near-term and long-term maternal and infant